Back
Leap Therapeutics Stock Predictions

Why Private Investors Didn't Lose a Penny in the Market's Recent $1T Crash
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
8
LPTX
Leap Therapeutics
Last Price:
$0.40
Seasonality Move:
9.9%
7 Day Trial
ALL ACCESS PASS
$
7

Apple just traded your privacy for $20 Billion
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Leap Therapeutics Stock Forecast
-
Is Leap Therapeutics Stock Undervalued?The current Leap Therapeutics [LPTX] share price is $0.40. The Score for LPTX is 8, which is 84% below its historic median score of 50, and infers higher risk than normal.
-
LPTX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
Will Leap Therapeutics Stock Go Up Next Year?
Data Unavailable
Leap Therapeutics Stock Rating
Data Unavailable
Leap Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
leaptx.com
52-Week Data
52-Week High:
4.79
52-Week Low:
0.39
Prediction Charts
Market Cap:
15.4M
Price in USD:
0.40
Volume:
227.2K
Beta:
0.61
Technical Analysis
SMA50:
1.13
SMA100:
2.13
SMA200:
2.26
52-Wk Change:
-84.27%
Stock Predictions
-
Is Leap Therapeutics stock public?Yes, Leap Therapeutics is a publicly traded company.
-
What is the Leap Therapeutics stock quote today?The Leap Therapeutics stock price is 0.40 USD today.
-
How to buy Leap Therapeutics stock online?You can buy Leap Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Mar-3 | 0.46 | 0.42 | 0.47 | 0.42 |
Mar-4 | 0.42 | 0.44 | 0.44 | 0.40 |
Mar-5 | 0.43 | 0.43 | 0.44 | 0.42 |
Mar-6 | 0.43 | 0.44 | 0.45 | 0.43 |
Mar-7 | 0.43 | 0.44 | 0.45 | 0.43 |
Mar-11 | 0.42 | 0.42 | 0.42 | 0.40 |
Mar-12 | 0.40 | 0.40 | 0.42 | 0.39 |
Mar-13 | 0.40 | 0.39 | 0.42 | 0.39 |
Mar-14 | 0.40 | 0.40 | 0.42 | 0.39 |
Mar-17 | 0.41 | 0.42 | 0.45 | 0.41 |
Mar-18 | 0.43 | 0.41 | 0.43 | 0.41 |
Mar-19 | 0.41 | 0.42 | 0.44 | 0.41 |
Mar-20 | 0.42 | 0.41 | 0.44 | 0.41 |
Mar-21 | 0.41 | 0.40 | 0.41 | 0.39 |
Leap Therapeutics Earnings
Data Unavailable
Leap Therapeutics Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and an increase next year of $0.04 per share.
* Leap Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.